Literature DB >> 16051604

Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins.

Faye Hui Chen1, Ashby O Thomas, Jacqueline T Hecht, Mary B Goldring, Jack Lawler.   

Abstract

Cartilage oligomeric matrix protein/thrombospondin 5 (COMP/TSP5) is a major component of the extracellular matrix of the musculoskeletal system. Although COMP/TSP5 abnormalities are associated with several pathological conditions, its normal function remains unclear. This study was undertaken to delineate the function(s) of COMP/TSP5 in cartilage, especially regarding its interaction with chondrocytes. We show that COMP/TSP5 can support chondrocyte attachment and that the RGD sequence in COMP/TSP5 and the integrin receptors alpha5beta1 and alphaVbeta3 on the chondrocytes are involved in mediating this attachment. The interactions of COMP/TSP5 with the integrins are dependent on COMP/TSP5 conformation. Chondrocyte attachment to COMP/TSP5 in the calcium-replete conformation was inhibited by function-blocking integrin alpha5 and beta1 antibodies, suggesting the involvement of the alpha5beta1 integrin. Under this condition, a function-blocking antibody against alphaVbeta3 did not have any effect on cell attachment. On the other hand, chondrocyte attachment to reduced COMP/TSP5 was instead sensitive to alphaVbeta3 function-blocking antibodies, suggesting that COMP/TSP5 mediates attachment through chondrocyte alphaVbeta3 integrin under this condition. Cell attachment to reduced COMP/TSP5 was not inhibited by beta1 antibodies. These data indicate that COMP/TSP5 in different conformations can utilize different integrin receptors. These results are the first to demonstrate that COMP/TSP5 can mediate chondrocyte attachment through interactions with integrins. Through these interactions, COMP/TSP5 may be able to regulate cellular activities and respond to environment in the surrounding cartilage matrix.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16051604      PMCID: PMC2896261          DOI: 10.1074/jbc.M504778200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

Review 1.  Thrombospondins as matricellular modulators of cell function.

Authors:  P Bornstein
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 2.  Thrombospondins: multifunctional regulators of cell interactions.

Authors:  J C Adams
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

Review 3.  Integrin-interleukin-4 mechanotransduction pathways in human chondrocytes.

Authors:  D M Salter; S J Millward-Sadler; G Nuki; M O Wright
Journal:  Clin Orthop Relat Res       Date:  2001-10       Impact factor: 4.176

4.  Properties of recombinant mouse thrombospondin 2 expressed in Spodoptera cells.

Authors:  H Chen; J Sottile; K M O'Rourke; V M Dixit; D F Mosher
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

5.  Cartilage oligomeric matrix protein and thrombospondin 1. Purification from articular cartilage, electron microscopic structure, and chondrocyte binding.

Authors:  P E DiCesare; M Mörgelin; K Mann; M Paulsson
Journal:  Eur J Biochem       Date:  1994-08-01

6.  Integrin-mediated attachment of articular chondrocytes to extracellular matrix proteins.

Authors:  R F Loeser
Journal:  Arthritis Rheum       Date:  1993-08

7.  COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins.

Authors:  A Oldberg; P Antonsson; K Lindblom; D Heinegård
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

8.  Integrin expression by human articular chondrocytes.

Authors:  V L Woods; P J Schreck; D S Gesink; H O Pacheco; D Amiel; W H Akeson; M Lotz
Journal:  Arthritis Rheum       Date:  1994-04

9.  Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes.

Authors:  M B Goldring; J R Birkhead; L F Suen; R Yamin; S Mizuno; J Glowacki; J L Arbiser; J F Apperley
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

10.  Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon.

Authors:  P DiCesare; N Hauser; D Lehman; S Pasumarti; M Paulsson
Journal:  FEBS Lett       Date:  1994-11-07       Impact factor: 4.124

View more
  58 in total

1.  The evolution of thrombospondins and their ligand-binding activities.

Authors:  Amber A Bentley; Josephine C Adams
Journal:  Mol Biol Evol       Date:  2010-04-28       Impact factor: 16.240

Review 2.  Thrombospondins and novel TSR-containing proteins, R-spondins, regulate bone formation and remodeling.

Authors:  Kurt D Hankenson; Mariya T Sweetwyne; Hailu Shitaye; Karen L Posey
Journal:  Curr Osteoporos Rep       Date:  2010-06       Impact factor: 5.096

3.  Granulin-epithelin precursor binds directly to ADAMTS-7 and ADAMTS-12 and inhibits their degradation of cartilage oligomeric matrix protein.

Authors:  Fengjin Guo; Yongjie Lai; Qingyun Tian; Edward A Lin; Li Kong; Chuanju Liu
Journal:  Arthritis Rheum       Date:  2010-07

Review 4.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

5.  Quantitative evaluation of the relationship between COMP promoter methylation and the susceptibility and curve progression of adolescent idiopathic scoliosis.

Authors:  Sai-Hu Mao; Bang-Ping Qian; Benlong Shi; Ze-Zhang Zhu; Yong Qiu
Journal:  Eur Spine J       Date:  2017-09-26       Impact factor: 3.134

Review 6.  Novel therapeutic interventions for pseudoachondroplasia.

Authors:  Karen L Posey; Jacqueline T Hecht
Journal:  Bone       Date:  2017-03-21       Impact factor: 4.398

7.  Enhanced activity of transforming growth factor β1 (TGF-β1) bound to cartilage oligomeric matrix protein.

Authors:  Dominik R Haudenschild; Eunmee Hong; Jasper H N Yik; Brett Chromy; Matthias Mörgelin; Kaylene D Snow; Chitrangada Acharya; Yoshikazu Takada; Paul E Di Cesare
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

8.  Ribozyme-mediated reduction of wild-type and mutant cartilage oligomeric matrix protein (COMP) mRNA and protein.

Authors:  Joseph L Alcorn; Thomas M Merritt; Mary C Farach-Carson; Huiqui H Wang; Jacqueline T Hecht
Journal:  RNA       Date:  2009-02-23       Impact factor: 4.942

9.  The crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin binding.

Authors:  Kemin Tan; Mark Duquette; Andrzej Joachimiak; Jack Lawler
Journal:  FASEB J       Date:  2009-03-10       Impact factor: 5.191

10.  An inducible cartilage oligomeric matrix protein mouse model recapitulates human pseudoachondroplasia phenotype.

Authors:  Karen L Posey; Alka C Veerisetty; Pieman Liu; Huiqiu R Wang; Brian J Poindexter; Roger Bick; Joseph L Alcorn; Jacqueline T Hecht
Journal:  Am J Pathol       Date:  2009-09-17       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.